GSK, Innoviva announce US nod for Trelegy Ellipta

19th September 2017 Uncategorised 0

GlaxoSmithKline and Innoviva have bagged a green light in the US for the novel triple therapy inhaler Trelegy Ellipta, opening the door to a new treatment option for patients with Chronic Obstructive Pulmonary Disorder (COPD).

More: GSK, Innoviva announce US nod for Trelegy Ellipta
Source: News